Researchers estimate 136 million adults, or about half the U.S. adult population, are eligible for semaglutide shots like Ozempic or Wegovy. That’s according to a new study published in JAMA Network ...

Most people regain some of the weight they lost after stopping semaglutide. However, physical activity and a balanced diet may help you keep some weight off. Share on Pinterest LeoPatrizi/Getty ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have been associated with at least 100 hospitalizations and 10 deaths ...

About 40% of American adults — some 137 million — are eligible to take the glucagon-like peptide 1 (GLP-1) receptor agonist semaglutide, said authors of a new study. Semaglutide will quickly ...

Get detailed information on Semaglutide, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated prescription ...

The ABC7 Chicago I-Team and ABC News are investigating the risks, and finding out how people are safely getting lower-cost ...

Compared with placebo, once-weekly semaglutide significantly reduced body weight, knee osteoarthritis-related pain, and improved physical function. Topline results were announced from a phase 3 ...

Ozempic, known generically as semaglutide, is an injectable prescription drug. It was approved in 2017 by the United States Food and Drug Administration (FDA) for use in adults with type 2 diabetes.

Watch Home News ...

Semaglutide led to statistically significantly fewer first admissions, total hospitalizations, and days hospitalized compared with placebo. Topline results were announced from an exploratory post hoc ...